This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n11http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023736%3A_____%2F06%3A00006851%21RIV09-MZ0-00023736/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023736%3A_____%2F06%3A00006851%21RIV09-MZ0-00023736
rdf:type
n11:Vysledek skos:Concept
dcterms:description
Léčba založená na stanovení rizika u myeloproliferativních onemocnění musí být založena na zvážení rizika trombózy a leukemogenicity hydroxyurey. Uvedena terapeutická doporučení České hematologické společnosti. Risk adapted treatment strategies in Ph- myeloproliferative disorders with thrombocythemia has to conform with the risks of thrombosis and the possible leukemogenicity of hydroxyurea. Treatment guidelines of the Czech Hematological Society are explained. Risk adapted treatment strategies in Ph- myeloproliferative disorders with thrombocythemia has to conform with the risks of thrombosis and the possible leukemogenicity of hydroxyurea. Treatment guidelines of the Czech Hematological Society are explained.
dcterms:title
Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia Analýza rizikových faktorů u léčby myeloproliferativních onemocnění : terapeutická doporučení České hematologické společnosti
skos:prefLabel
Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia Analýza rizikových faktorů u léčby myeloproliferativních onemocnění : terapeutická doporučení České hematologické společnosti
skos:notation
RIV/00023736:_____/06:00006851!RIV09-MZ0-00023736
n3:aktivita
n13:V
n3:aktivity
V
n3:cisloPeriodika
3
n3:dodaniDat
n16:2009
n3:domaciTvurceVysledku
n10:9564918 n10:2508354
n3:druhVysledku
n9:J
n3:duvernostUdaju
n15:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
464970
n3:idVysledku
RIV/00023736:_____/06:00006851
n3:jazykVysledku
n6:eng
n3:klicovaSlova
myeloproliferative disorders; treatment guidelines; risk factors; thrombosis; thrombophilia; leukemogenicity of hydroxyurea; interferon; anagrelide
n3:klicoveSlovo
n5:myeloproliferative%20disorders n5:anagrelide n5:thrombosis n5:interferon n5:leukemogenicity%20of%20hydroxyurea n5:risk%20factors n5:treatment%20guidelines n5:thrombophilia
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[E7437CD2B7FC]
n3:nazevZdroje
Seminars in Thrombosis and Hemostasis
n3:obor
n4:FD
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
8
n3:rokUplatneniVysledku
n16:2006
n3:svazekPeriodika
32
n3:tvurceVysledku
Dulíček, P. Schwarz, Jiří Křen, L. Pytlík, R. Brychtová, Y. Campr, Vít Penka, M. Doubek, M.
n3:wos
000237356400006
s:issn
0094-6176
s:numberOfPages
15